Another risky Alzheimer’s dud being fast-tracked by FDA
September 8, 2016 – Only in Big Pharma’s world could a drug like this be called a “game changer.” But when you’re talking about a med for Alzheimer’s disease, it appears there’s a new playbook out that drugmakers — and the FDA — are following. Despite the fact that the trial for this new... Read More >


